Page 41 - MI-2-2
P. 41

Microbes & Immunity                                                     Genetic therapy with HSV-1 vectors



            88.  Murphy CG, Lucas WT, Means RE, et al. Vaccine protection   93.  Chattopadhyay M, Krisky D, Wolfe D, Glorioso JC, Mata M,
               against  simian  immunodeficiency  virus  by  recombinant   Fink DJ. HSV-mediated gene transfer of vascular endothelial
               strains of herpes simplex virus. J Virol. 2000;74(17):7745-7754.  growth factor to dorsal root ganglia prevents diabetic
                                                                  neuropathy. Gene Ther. 2005;12(18):1377-1384.
               doi: 10.1128/jvi.74.17.7745-7754.2000
                                                                  doi: 10.1038/sj.gt.3302533
            89.  Liu X, Broberg E, Watanabe D, Dudek T, Deluca N, Knipe
               DM. Genetic engineering of a modified herpes simplex virus   94.  Bolognani F, Goya RG. Gene therapy in the neuroendocrine
               1 vaccine vector. Vaccine. 2009;27(21):2760-2767.  system: Its implementation in experimental models using
                                                                  viral vectors. Neuroendocrinology. 2001;73(2):75-83.
               doi: 10.1016/j.vaccine.2009.03.003
                                                                  doi: 10.1159/000054623
            90.  Wilson  SP, Yeomans DC,  Bender MA,  Lu Y, Goins WF,
               Glorioso JC. Antihyperalgesic effects of infection with a   95.  Wolfe D, et al. Safety and biodistribution studies of an HSV
                                                                  multigene vector following intracranial delivery to non-
               preproenkephalin-encoding herpes virus.  Proc Natl Acad   human primates. Gene Ther. 2004;11(23):1675-1684.
               Sci U S A. 1999;96(6):3211-3216.
                                                                  doi: 10.1038/sj.gt.3302336
               doi: 10.1073/pnas.96.6.3211
                                                               96.  Perez MC, Hunt SP, Coffin RS, Palmer JA. Comparative
            91.  Goss JR, Harley CF, Mata M, et al. Herpes vector-mediated   analysis of genomic HSV vectors for gene delivery to motor
               expression of proenkephalin reduces bone cancer pain. Ann   neurons following peripheral inoculation in vivo. Gene Ther.
               Neurol. 2002;52(5):662-665.                        2004;11(13):1023-1032.
               doi: 10.1002/ana.10343                             doi: 10.1038/sj.gt.3302258
            92.  Berto E, Bozac A, Marconi P. Development and application   97.  Walther W, Stein U. Viral vectors for gene transfer: A review
               of replication-incompetent HSV-1-based vectors.  Gene   of their use in the treatment of human diseases.  Drugs.
               Ther. 2005;12 Suppl 1:S98-S102.                    2000;60(2):249-271.
               doi: 10.1038/sj.gt.3302623                         doi: 10.2165/00003495-200060020-00002













































            Volume 2 Issue 2 (2025)                         33                               doi: 10.36922/mi.7947
   36   37   38   39   40   41   42   43   44   45   46